Sentry Investment Management LLC trimmed its position in shares of CVS Health Corp (NYSE:CVS) by 6.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 71,995 shares of the pharmacy operator’s stock after selling 5,099 shares during the quarter. Sentry Investment Management LLC’s holdings in CVS Health were worth $5,793,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Fieldpoint Private Securities LLC raised its position in shares of CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares in the last quarter. Gemmer Asset Management LLC raised its position in shares of CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares in the last quarter. Captrust Financial Advisors purchased a new position in CVS Health during the 2nd quarter worth approximately $155,000. Grace & White Inc. NY purchased a new position in CVS Health during the 2nd quarter worth approximately $199,000. Finally, Nadler Financial Group Inc. purchased a new position in CVS Health during the 2nd quarter worth approximately $202,000. Institutional investors own 82.24% of the company’s stock.

CVS Health Corp (NYSE:CVS) opened at $70.80 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The stock has a market capitalization of $72,550.49, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. CVS Health Corp has a one year low of $66.45 and a one year high of $84.72.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the company posted $1.64 EPS. equities research analysts predict that CVS Health Corp will post 5.9 earnings per share for the current year.

A number of research analysts recently issued reports on the company. Raymond James Financial restated a “buy” rating on shares of CVS Health in a research note on Monday, December 4th. Deutsche Bank restated a “hold” rating on shares of CVS Health in a research note on Tuesday, December 5th. Royal Bank of Canada set a $95.00 price objective on CVS Health and gave the stock a “buy” rating in a report on Monday, December 4th. Robert W. Baird set a $77.00 price objective on CVS Health and gave the stock a “hold” rating in a report on Monday, December 4th. Finally, Jefferies Group set a $76.00 price target on CVS Health and gave the stock a “hold” rating in a report on Monday, December 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $86.35.

In other CVS Health news, COO Jonathan C. Roberts sold 85,743 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the completion of the transaction, the chief operating officer now directly owns 119,555 shares of the company’s stock, valued at approximately $9,939,802.70. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the transaction, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “CVS Health Corp (CVS) Shares Sold by Sentry Investment Management LLC” was posted by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/12/15/cvs-health-corp-cvs-shares-sold-by-sentry-investment-management-llc.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.